Better Science, Better Health: New Healthcare Models – Speakers Better Science, Better Health: New Healthcare Models Join the conversation on twitter #BSBH15 Speakers:Click on the pictures for the biograhiesSabine Atzor, Director Regulatory Affairs, Part time seconded from F.Hoffmann-La Roche to EFPIA Richard Barker Founding Director, CASMI Nancy Berg CEO, ISPOR Jeff Brown Associate Professor Population Medicine, Harvard Medical School Michael C Burgess, M.D. US Congressman Bill Cassidy, M.D. United States Senator for Louisiana Ruxandra Draghia-Akli Director Health, DG Research and Innovation, European Commission David A. Dworaczyk Director, Life and Health Sciences Strategic Development, Oracle Health Sciences Hans-Georg Eichler Senior Medical Officer, European Medicines Agency Laura Esserman, MD MBA Professor of Surgery and Radiology, Director UCSF Carol Franc Buck Breast Care Center Pat Furlong Founding President and CEO, Parent Project Muscular Dystrophy Sarah Garner Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE) Joseph P. Hammang Partner, Vital Transformation Adam Heathfield Senior Director Global Health and Value Innovation Center, Pfizer Gigi Hirsch Executive Director, MIT NEWDIGS Ryan Hohman Managing Director, Policy & Public Affairs, Friends of Cancer Research Lynn D. Hudson Chief Science Officer for the Critical Path Institute (C-Path) Alastair Kent Director, Genetic Alliance UK Carol Linden Director Office of Regulatory Science and Innovation, FDA Barbara Lopez Kunz Global Chief Executive, DIA Pierre Meulien Executive Director, Innovative Medicines Initiative Sandra A. Milligan, Senior Vice President, Head of Regulatory Affairs and Safety Merck Research Laboratories Anders Olauson President, European Patients’ Forum Kenneth Oye Associate Professor of Political Science and Engineering Systems, MIT Dainius Pavalkis Professor, Lithuanian University of Health Sciences Mark Pearson Deputy Director for Employment Labour and Social Affairs, Organisation for Economic Co-operation and Development (OECD) Arti K. Rai Elvin R. Latty Professor of Law and co-Director, Duke Law Center for Innovation Policy, Duke University Bettina Ryll Founder, Melanoma Patient Network Peter L. Saltonstall CEO, National Organization of Rare Disorders (NORD) Vicki Seyfort – Margolis CEO, My Own Med Duane Schulthess Managing Director, Vital Transformation Jonathan Sheldon Global Vice President Healthcare, Oracle Health Sciences Mark Trusheim Executive-in-Residence, MIT Jocelyn Ulrich Senior Director, Science & Regulatory Advocacy, PhRMA Bart Vannieuwenhuyse Senior Director Health Information Sciences, Janssen Pharmaceuticals Sheldon Whitehouse United States Senator for Rhode Island John Wubbe Secretary General, Epposi Supported by:Sponsored by: bsbh2018-03-06T12:07:31+02:00